J4 ›› 2009, Vol. 35 ›› Issue (6): 1068-1073.

• 基础研究 • 上一篇    下一篇

转录介导融合基因RBM6-RBM5在肿瘤细胞及组织中的表达

 王珂1, 张捷1, 李然伟2   

  1. 1. 吉林大学第二医院呼吸内科,吉林 长春 130041;2. 吉林大学第二医院泌尿外科,吉林 长春 130041
  • 收稿日期:2009-04-22 出版日期:2009-11-28 发布日期:2009-11-28
  • 通讯作者: 王 珂 E-mail:kewangm1@hotmail.com
  • 作者简介:王 珂(1968-)| 女| 吉林省长春市人| 副教授| 医学博士| 主要从事肺感染性疾病及肿瘤方面的研究。
  • 基金资助:

    吉林省科技厅科研基金资助课题 (200505131)

Expression of RBM6-RBM5 transcription-induced chime rain tumor cells and tissues

 WANG Ke1, ZHANG Jie1, LI Ran-Wei2   

  1. 1.  |Department of Respiratory Medicine,Second Hospital,Jilin University,Changchun 130041,China;2. Department of Urinary Surgery,Second Hospital,Jilin University,Changchun 130041,China)
  • Received:2009-04-22 Online:2009-11-28 Published:2009-11-28

摘要:

目的: 鉴定RBM6-RBM5融合基因的存在,研究其与肿瘤发生的关系。方法:采用GLC20、MDA、MB、231、 Jurkat、TF-1、MCF-7、Hela、BT-474、A431、K562及Raji 10种肿瘤细胞株,肺、卵巢、骨骼肌、皮肤、脾脏、子宫、心脏、骨、脑、淋巴结、胰腺、前列腺及睾丸等肿瘤组织及其相应正常对照组织的cDNA,5例乳腺癌组织,以巢式PCR方法检测融合基因的存在,并通过QPCR方法研究融合基因的产生与RBM6、RBM5基因表达水平之间的关系。结果:RBM6-RBM5融合基因首次在MDA、MB、231细胞株中获得鉴定,序列分析发现该基因为RBM
6和RBM5的融合体,该融合体不包括RBM6的外显子20、21以及RBM5的外显子1。该融合基因在10种肿瘤细胞株及部分肿瘤组织中表达,但在正常组织中却未见表达。融合基因的表达与RBM6和RBM5 mRNA 的表达有关;RBM6和RBM5 mRNA的表达水平在融合基因阳性的肿瘤组织中明显高于融合基因阴性的肿瘤组织。结论:融合基因的表达与肿瘤发生有关,高水平的RBM6和RBM5 mRNA水平可能是融合基因产生的原因之一。 
[关键词] RNA结合基序蛋白; 转录介导融合基因;肿瘤细胞,培养的

关键词:  RNA结合基序蛋白; 转录介导融合基因;肿瘤细胞, 培养的

Abstract:

Objective
 To determine the existence of RBM6-RBM5 chimera and study its relationship with oncogenesis. Methods Ten cell lines including GLC-20,MDA.MB.231, Jurkat,TF-1,MCF-7,Hela,BT-474,A431,K562 and Raji ; several cDNAs from tumor tissues including lung,ovary,skeletal,skin,spleen,uterus,heart,bone,brain,lymph node,pancreas,prostate,testis  and their normal controls and 5 breast cancer tissues were collected for the study.Nested PCR was used to identify the existence and expression level of RBM6-RBM5 chimera.QPCR was used to determine the RBM6,RBM5 gene expression level in chimeric positive and negative tumor tissues.Results RBM6-RBM5 chimera was identified in MDA,MB,231 cell line,which lacked exons 20,21 of RBM6 and exon 1 of RBM5.The chimeric expression was only observed on 10 tumor cell lines and tissues,among some specific tumor types,the chimeric expression was associated with elevated levels of RBM6 and RBM5 mRNA.Conclusion  RBM6 mRNA experiences altered co-transcriptional gene regulation in certain cancers.RBM6-RBM5 transcription-induced chimerism might be a process that is linked to the tumor-associated increased transcriptional activity of the RBM6 and RBM5 genes,and this chimera might be a new marker for tumor prediction. 
〖WTHZ〗Key words:RNA binding motif protein;transcription-induced chimera;tumor cells,cultured

Key words: RNA binding motif protein;transcription-induced chimera;tumor cells,cultured

中图分类号: 

  •